Regeneron’s bispecific antibody linvoseltamab, now branded as Lynozyfic, has received conditional approval from the European ...

Watch how Beacon Discovery™, Bruker Cellular Analysis’s accessible, compact, and flexible platform, is redefining live single-cell functional analysis, bringing deeper biological insights to every lab ...